Dudediligence.

Armata Pharmaceuticals, Inc

ARMPAMEX · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$5.5MSep ’24$2.6MDec ’24−$6.5MMar ’25−$16.3MJun ’25−$26.7MSep ’25−$124.3MDec ’25−$115.3MMar ’26$74.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$23.8M−$36.9M−$40.9M−$42.4M−$36.6M
Net income−$23.2M−$36.9M−$69.0M−$18.9M−$173.8M
Operating cash flow−$23.6M−$32.5M−$47.4M−$37.6M−$25.8M
Free cash flow−$24.9M−$34.7M−$55.6M−$39.4M−$26.3M
Cash$10.3M$14.9M$13.5M$9.3M$8.7M
Shares outstanding27.1M36.1M36.1M36.2M36.4M